3 proposals for ‘thinking outside the box’ in public health emergencies
April 2, 2015
| By Mary Engel / Fred Hutch News Service
In a perspective published today in the journal Science, researchers from Fred Hutchinson Cancer Research Center and other institutions drew on lessons learned in the ongoing Ebola epidemic in West Africa to suggest guidelines for conducting vaccine clinical trials during an infectious disease emergency.
Vaccine potentially could be used in the majority of breast cancer patients
Dec. 3, 2014
| By Diane Mapes / Fred Hutch News Service
They may be baby steps, but researchers at Washington University School of Medicine in St. Louis took a few more of them this week with the publication of a study looking at a potential new breast cancer vaccine. Fred Hutch researchers weigh in and discuss their own breast cancer vaccine-related work.
Vaccine and Infectious Disease Institute researchers co-author study on vaccine with potential to prevent the most common virus transmitted by a pregnant woman to her unborn child
March 23, 2009
A new vaccine that has the potential to be the first to prevent maternal and congenital cytomegalovirus (CMV) infection was detailed in a study published in the March 19 edition of the New England Journal of Medicine. Dr. Larry Corey, co-director of the Hutchinson Center’s Vaccine and Infectious Disease Institute, and Dr. Meei-li Huang, of VIDI and a research scientist in the Virology Division at the University of Washington and an affiliate member in VIDI, were co-authors of the paper with colleagues at the University of Alabama at Birmingham, who led the study.